Yang Lei
Senior Director, Biostatistics at Atea Pharmaceuticals, Inc- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Atea Pharmaceuticals, Inc
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Senior Director, Biostatistics
-
Feb 2022 - Present
-
-
-
Spero Therapeutics
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Director, Head of Biostatistics
-
May 2020 - Feb 2022
Infectious disease Infectious disease
-
-
-
Biogen
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Associate Director
-
Oct 2018 - May 2020
Real World Evidence Strategy and Analytics MSF Scientific Leadership Council Neurology Real World Evidence Strategy and Analytics MSF Scientific Leadership Council Neurology
-
-
-
AbbVie
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Manager, statistics
-
May 2016 - Oct 2018
Therapeutical areas: virology, oncology New Drug Application (NDA/MAA) Phase 2, Phase 3, Phase 3b Clinical trials Real World Evidence (RWE) Post Marketing Observational Studies Therapeutical areas: virology, oncology New Drug Application (NDA/MAA) Phase 2, Phase 3, Phase 3b Clinical trials Real World Evidence (RWE) Post Marketing Observational Studies
-
-
-
St Luke's Hospital kansas city
-
Kansas City, Missouri Area
-
Senior Biostatistician
-
May 2007 - May 2016
Therapeutical area: cardiology Industry or government sponsored studies Health Economics and Outcomes Research Quality of Life (QoL) and cost-effectiveness analysis Therapeutical area: cardiology Industry or government sponsored studies Health Economics and Outcomes Research Quality of Life (QoL) and cost-effectiveness analysis
-
-
-
-
Co op
-
May 2006 - Dec 2006
-
-
Education
-
University of Iowa
Master's degree, Biostatistics -
University of Kansas Medical Center
Doctor of Philosophy (Ph.D.), Biostatistics
Community
